Recombinant factor VIIa (NovoSeven®) restores deficient coagulation:: Experience from an ex vivo model

被引：14

作者：

Galán, AM

Tonda, R

Altisent, C

Maragall, S

Ordinas, A

Escolar, G

机构：

[1] Univ Barcelona, Hosp Clin, IDIBAPS, Serv Hemoterapia Hemostasia, Barcelona, Spain

[2] Hosp Gen Valle Hebron, Unitat Hemofilia, Barcelona, Spain

来源：

SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 04期

关键词：

D O I：

10.1016/S0037-1963(01)90141-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：10 / 14

页数：5

共 30 条

[21] TISSUE FACTOR-INDUCED COAGULATION TRIGGERS PLATELET THROMBUS FORMATION AS EFFICIENTLY AS FIBRILLAR COLLAGEN AT ARTERIAL BLOOD-FLOW CONDITIONS [J].

ORVIM, U ;

ROALD, HE ;

STEPHENS, RW ;

ROOS, N ;

SAKARIASSEN, KS .

ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (12) :1976-1983

[22] Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: Safety, monitoring, and cost effectiveness [J].

Schulman, S .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :421-424

[23]

SULTAN Y, 1993, J LAB CLIN MED, V121, P444

[24]

TURITTO VT, 1983, METHODS HEMATOLOGY M, V8, P46

[25] BLEEDING COMPLICATIONS IN ORAL ANTICOAGULANT-THERAPY - AN ANALYSIS OF RISK-FACTORS [J].

VANDERMEER, FJM ;

ROSENDAAL, FR ;

VANDENBROUCKE, JP ;

BRIET, E .

ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (13) :1557-1562

[26] ROLE OF SHEAR RATE AND PLATELETS IN PROMOTING FIBRIN FORMATION ON RABBIT SUBENDOTHELIUM - STUDIES UTILIZING PATIENTS WITH QUANTITATIVE AND QUALITATIVE PLATELET DEFECTS [J].

WEISS, HJ ;

TURITTO, VT ;

BAUMGARTNER, HR .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (04) :1072-1082

[27] FURTHER-STUDIES ON THE PRESENCE OF FUNCTIONAL TISSUE FACTOR ACTIVITY ON THE SUBENDOTHELIUM OF NORMAL HUMAN AND RABBIT ARTERIES [J].

WEISS, HJ ;

HOFFMANN, T ;

TURITTO, VT ;

NEMERSON, Y .

THROMBOSIS RESEARCH, 1994, 73 (05) :313-326

[28]

WEISS HJ, 1988, BLOOD, V71, P629

[29] FIBRIN FORMATION, FIBRINOPEPTIDE-A RELEASE, AND PLATELET THROMBUS DIMENSIONS ON SUBENDOTHELIUM EXPOSED TO FLOWING NATIVE BLOOD - GREATER IN FACTOR-XII AND FACTOR-XI THAN IN FACTOR-VIII AND FACTOR-IX DEFICIENCY [J].

WEISS, HJ ;

TURITTO, VT ;

VICIC, WJ ;

BAUMGARTNER, HR .

BLOOD, 1984, 63 (05) :1004-1014

[30] Management and prognosis of life-threatening bleeding during warfarin therapy [J].

White, RH ;

McKittrick, T ;

Takakuwa, J ;

Callahan, C ;

McDonell, M ;

Fihn, S .

ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (11) :1197-1201

← 1 2 3 →